
Sign up to save your podcasts
Or


VSD's Editor in Chief Sharon Spielman interviews Bill Rader, CEO of Efferent Labs, about a new research platform that utilizes live cellular data for testing new drugs to treat chronic diseases.
By Endeavor Business MediaVSD's Editor in Chief Sharon Spielman interviews Bill Rader, CEO of Efferent Labs, about a new research platform that utilizes live cellular data for testing new drugs to treat chronic diseases.